BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3006391)

  • 1. [Cytodiagnosis of invasive ductal breast cancer].
    Finsterer H
    Verh Dtsch Ges Pathol; 1985; 69():502-7. PubMed ID: 3006391
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery].
    Bässler R
    Strahlenther Onkol; 1996 Feb; 172(2):110-1. PubMed ID: 8669044
    [No Abstract]   [Full Text] [Related]  

  • 3. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
    Andersen J; Nielsen M; Christensen L
    Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 6. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microinvasive carcinoma of the breast: a diagnosis in search of a definition.
    Schnitt SJ
    Adv Anat Pathol; 1998 Nov; 5(6):367-72. PubMed ID: 10095878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-stage breast cancer rates rise sharply as invasive breast cancer levels off.
    Oncology (Williston Park); 2005 Aug; 19(9):1176. PubMed ID: 16404785
    [No Abstract]   [Full Text] [Related]  

  • 10. The significance of intraduct appearances in breast cancer.
    Cowen PN; Bates C
    Clin Oncol; 1984 Mar; 10(1):67-72. PubMed ID: 6323084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine needle aspiration cytology of "minimal" breast cancer.
    Matsuda M; Nagumo S; Koyama H; Terasawa T
    Acta Cytol; 1986; 30(5):501-4. PubMed ID: 3022516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-morphological parallels in different histological variants of breast cancer].
    Belikov GN
    Khirurgiia (Mosk); 1983 Nov; (11):48-52. PubMed ID: 6319796
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
    Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of TRAF4 protein in breast carcinoma].
    Dai WB; Zheng YW; Mi XY; Liu N; Lin H; Yan J
    Ai Zheng; 2007 Oct; 26(10):1095-8. PubMed ID: 17927880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast cancer from the viewpoint of the pathologist].
    Reiner A
    Wien Med Wochenschr; 2000; 150(4):58-62. PubMed ID: 10829305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytomorphology and prognosis of invasive breast cancer--recommendation for cytologic grading and personal experiences].
    Schöndorf NK; Neis KJ; Gräber S
    Verh Dtsch Ges Pathol; 1985; 69():532-6. PubMed ID: 3006393
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding ductal carcinoma in situ: a step in the right direction.
    Morrow M
    Cancer; 1999 Aug; 86(3):375-7. PubMed ID: 10430242
    [No Abstract]   [Full Text] [Related]  

  • 20. Biology of ductal carcinoma in situ classification based on biologic potential.
    Tsikitis VL; Chung MA
    Am J Clin Oncol; 2006 Jun; 29(3):305-10. PubMed ID: 16755185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.